My watch list
my.bionity.com  
Login  

59 Current news from russian federation

rss

You can refine your search further. Select from the filter options on the left to narrow down your results.

Evolva obtains patent coverage in Russia on EV-077 for use in complications of diabetes

15-Dec-2011

Evolva Holding SA announced that the Russian Patent Office has granted patent protection for EV-077 in the treatment of complications of diabetes for a term extending to 2026. This is the first patent granted covering EV-077. EV-077 patent applications are currently pending in Australia, Brazil, ...

more

Evonik establishes joint venture in Russia to produce feed amino acid L-lysine

Growing demand for biotechnology-manufactured L-lysine in Russia

05-Oct-2011

Evonik Industries and Russian company RusBiotech International have established the joint venture Russkie Biotechnologii for manufacturing L-lysine in Russia by means of a biotechnological process. Vassily Golubev, governor of the Rostov-on-Don region, and Vadim Varshavsky, a deputy of the State ...

more

Novartis begins construction of new state-of-the-art pharmaceutical manufacturing plant in St. Petersburg, Russia

Facility expected to be complete by 2014, planned to manufacture pharmaceuticals and high-quality generics

20-Jun-2011

Novartis held a groundbreaking ceremony to announce the start of construction of a pharmaceutical manufacturing plant in St. Petersburg, Russia. The construction of this facility represents the most significant Novartis investment in Russia to date. This facility will further expand the company's ...

more

Pharmsynthez granted Orphan Drug Designation for Virexxa in the US

01-Mar-2011

Pharmsynthez announced that the United States Food and Drug Administration (FDA) has unanimously awarded Virexxa, OJSC Pharmsynthez’s treatment for hormonotherapy-resistant endometrial cancer (a malignant tumor of the female reproductive system), orphan drug designation.Virexxa is the first ...

more

M+W Group is to set up a biotechnology plant in Siberia

05-Nov-2010

M+W Group has signed a letter of intent for design and construction of a biotechnology plant complex in the Siberian town of Omsk. This was announced at the German-Russian raw materials forum taking place in Moscow. Contracting partner of M+W Group are the governor of Omsk, Mr. Leonid K. ...

more

Novartis announces Russian regulatory approval for Gilenya, a once-daily oral multiple sclerosis therapy

13-Sep-2010

The Russian health authority, the Federal Service on Surveillance in Healthcare and Social Development, has granted approval for Gilenya® (fingolimod) 0.5 mg once-daily oral therapy for the treatment of relapsing remitting multiple sclerosis (MS). Approximately 85% of patients with MS are ...

more

Scientists identify virulent new strains of Ug99 stem rust

Wheat experts report progress toward replacing 5 percent of vulnerable fields in nations at risk

28-May-2010

Four new mutations of Ug99, a strain of a deadly wheat pathogen known as stem rust, have overcome existing sources of genetic resistance developed to safeguard the world's wheat crop. Leading wheat experts from Australia, Asia, Africa, Europe and the Americas, who are in St. Petersburg, Russia ...

more

Affitech Signs Strategic Alliance with Russian Biotech Partner

23-Apr-2010

NauchTekhStroy Plus (NTS Plus), a newly formed joint venture subsidiary of Pharmstandard will conduct clinical development and registration of two Affitech antibodies for Russian and CIS markets. NTS Plus will pay €23 million in fees and advanced royalties to Affitech. Pharmstandard will ...

more

OPK Biotech Develops Research and Production in Russia

12-Oct-2009

Biopure Corporation was finally taken under OPK Biotech's control, a part of the United Industrial Corporation (OPK). OPK Biotech has high-qualified specialists and managers in the domain of biochemistry and finance. All top-managers possess academic degrees and scientific education from leading ...

more

Page 6 From 6
Subscribe to e-mail updates relating to your search

You will receive via e-mail the latest search results matching your search criteria. This service is free of charge and can be cancelled at any time.

Your browser is not current. Microsoft Internet Explorer 6.0 does not support some functions on Chemie.DE